Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

NCT05064358

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chattanooga, Tennessee, United States
View all 77 locations
View Trial Details
Completed

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

NCT02719613

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 0020 Tucson, Arizona, United States
  • Local Institution - 0017 Bakersfield, California, United States
  • Local Institution - 0022 Fountain Valley, California, United States
  • Local Institution - 0016 West Hollywood, California, United States
View all 41 locations
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)

NCT04557150

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peter MacCallum Cancer Center Melbourne, Victoria, Australia
  • UZ Gent Ghent, Belgium
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital Odense C, Denmark
View all 20 locations
View Trial Details
Completed

A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

NCT03984097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Pacific Cancer Care Monterey, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma

NCT02302495

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centre Hospitalier H. Duffaut Avignon, France
  • Centre Hospitalier de la côte basque Bayonne, France
  • Hôpital Jean Minjoz Besançon, France
  • Institut Bergonie Bordeaux, France
View all 33 locations
View Trial Details

Related conditions